Single-Agent Regimens Fall Short in DLBCL Single-Agent Regimens Fall Short in DLBCL

Single-agent regimens are most likely not efficient enough to substantially improve the outcome of patients with diffuse large B-cell lymphoma (DLBCL).Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news